Allworth Financial’s Catheter Precision VTAK Stock Holding History

Allworth Financial’s Portfolio VTAK Stock Details VTAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$255	Hold	300	–	–	﹤0.01%	4924
2026 Q1	$303	Buy	+300	New	+$508	﹤0.01%	4845

Other funds holding VTAK

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PUI

Purpose Unlimited Inc Toronto $2.62B AUM

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Allworth Financial's VTAK Position: Q2 2026 in Review

Allworth Financial held its Catheter Precision (VTAK) position steady in Q2 2026 at 300 shares worth $255. The position accounts for ﹤0.01% of the portfolio, ranked #4924.

Allworth Financial first reported a position in VTAK in Q1 2026 and has held it in 2 quarters since. The position peaked at $303 in Q1 2026. 10 funds tracked by Wall St. Rank hold VTAK as of Q2 2026.

Allworth Financial held 300 shares of Catheter Precision worth $255 as of Q2 2026.
Allworth Financial left its Catheter Precision share count unchanged in Q2 2026.
Catheter Precision made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4924 holding.
Allworth Financial first reported a position in Catheter Precision in Q1 2026 and has held it in 2 quarters since.
Allworth Financial's Catheter Precision position peaked at $303 in Q1 2026.
10 funds tracked by Wall St. Rank held Catheter Precision as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.